How Do We Move Type 1 Diabetes Immunotherapies Forward During the Current COVID-19 Pandemic?

Research-based immunotherapy trials seeking to prevent or reverse a number of autoimmune diseases, including type 1 diabetes, have seen near universal suspension due to the coronavirus disease 2019 (COVID-19) pandemic, caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Diabetes...

Descripción completa

Detalles Bibliográficos
Autores principales: Haller, Michael J., Jacobsen, Laura M., Posgai, Amanda L., Schatz, Desmond A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Diabetes Association 2021
Materias:
Perspectives in Diabetes
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8173800/
https://www.ncbi.nlm.nih.gov/pubmed/33632743
http://dx.doi.org/10.2337/dbi20-0045

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8173800/
https://www.ncbi.nlm.nih.gov/pubmed/33632743
http://dx.doi.org/10.2337/dbi20-0045

Ejemplares similares